Concerns Raised About MDMA-Assisted Psychotherapy Trials for PTSD

May 17, 2024

BetterLife’s Non-Hallucinogenic LSD Derivative Clears Safety Hurdle

May 15, 2024

Compass Pathways COMP360 Delivers on Phase 2 Results

May 9, 2024

Psychedelics Without the Trip Show Antidepressant Potential

May 9, 2024

BetterLife Pharma Set to Begin Human Trials for LSD Derivative

May 3, 2024

Preserving a Legacy: Wendy Tucker’s Vision for Shulgin Farm

April 26, 2024